Study of LM-299 in Subjects Advanced Malignant Tumors

Clinical trial NCT06650566 · RECRUITING

Trial details

NCT number: NCT06650566
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Tumors

Start date: 2024-10-09
Primary completion: 2026-12-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.